Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
2.130
+0.120 (5.97%)
Oct 29, 2026, 4:00 PM EDT - Market closed
KLRS's stock price has decreased by -57.4% in the past year and price targets may not have had time to catch up.
Kalaris Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $14 | Buy | Reiterates | $14 | +557.28% | Aug 12, 2026 |
| Wedbush | Wedbush | Buy Reiterates $17 | Buy | Reiterates | $17 | +698.12% | Aug 11, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 11, 2026 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 15, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $26 → $25 | Buy | Maintains | $26 → $25 | +1,073.71% | May 13, 2026 |